Histocompatibility locus antigens (HLA) in the epidermoid type of lung carcinoma
- 1 September 1990
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 116 (5), 525-527
- https://doi.org/10.1007/bf01613006
Abstract
HLA-A and B antigens were determined in a study of 162 patients (93 epidermoid type, 20 adenocarcinoma, 26 small-cell carcinoma and 23 undifferentiated types) with lung cancer. Differences between antigen frequencies in cancer and control populations were studied by χ Y 2 analysis or Fisher's exact test. Survival data were analyzed using Cox's model for censored data. Cancer patients had a decreased frequency of the antigen HLA-B40 (χ Y 2 =14.15,P=0.00018,P c=0.003, relative risk=0.21). Patients with HLA-A10, A 11 and B27 had a shortened mean survival time. Patients with HLA-B12 had a prolonged survival time.Keywords
This publication has 10 references indexed in Scilit:
- HLA and survival in lung cancerClinical Immunology and Immunopathology, 1987
- Histocompatibility antigens in small cell carcinoma of the lungCancer, 1984
- Medical Leech RevisitedNew England Journal of Medicine, 1982
- HLA Antigens and primary bronchial carcinomaCancer, 1982
- HLA frequency and prognosis in lung cancerBritish Journal of Cancer, 1981
- NOTE ON RELATIVE RISKS1977
- A Note on Relative Risks*Tissue Antigens, 1977
- Prolonged Survival in Bronchogenic Carcinoma Associated With HL-A Antigens W-19 and HL-A5: A Preliminary ReportJNCI Journal of the National Cancer Institute, 1975
- HL‐A Antigens and Disease Statistical and Genetical ConsiderationsTissue Antigens, 1974
- SEROTYPING FOR HOMOTRANSPLANTATION XVIII. REFINEMENT OF MICRODROPLET LYMPHOCYTE CYTOTOXICITY TESTTransplantation, 1968